CN111548961A is a patent for a probiotic formula for alleviating allergies. The formula contains 6 bacterial species, L. johnsonii LBJ456, L. casei PB-LC39, L. paracasei HH-LP58, L. plantarum HH-LP56, L. rhamnosus PB-LR76, and L. reuteri PB-LR09, and does not include the 8 common allergens. The formula is applicable to many different groups of people, such as children, adults, women, and elderly, and has a great advantage in alleviating and ameliorating common allergic responses, especially in children. Furthermore, it is available in many different forms, such as capsules, syrups, and powders, and can also be produced as OEM and ODM products according to customer requests.
The working mechanism of this formula rests on the probiotic properties of the bacterial species specified in the patent. The bacteria in the formula create a protective barrier in the gut that prevents allergens from penetrating the intestinal wall. Furthermore, the bacteria produce natural enzyme that inhibit the formation of antibodies. Lastly, the probiotics stimulate the production of regulatory T cells, which, in turn, inhibit and reduce the allergen response.
Through this combination of mechanisms, the formula can effectively alleviate and ameliorate common allergic responses. Through its versatility and availability in multiple forms, it is possible to find the appropriate solution for any patients' needs.
For more details pelase visit: https://www.probioway.com/probiotic-supplements/allergy-probiotics-capsule.html